Copyright
©The Author(s) 2019.
World J Stem Cells. Dec 26, 2019; 11(12): 1115-1129
Published online Dec 26, 2019. doi: 10.4252/wjsc.v11.i12.1115
Published online Dec 26, 2019. doi: 10.4252/wjsc.v11.i12.1115
Treatment (dose) | Roughness of surface | Adhesion with meniscus | Hypertrophy of joint | Osteophyte | Total score |
(0-8) | (0-8) | (0-8) | (0-8) | (0-32) | |
ACLT alone | 5.5 ± 0.5 | 4.5 ± 0.5 | 6.0 ± 0.4 | 4.0 ± 2.0 | 20.0 ± 3.1 |
hADMSCs (low) | 4.0 ± 1.0 | 4.0 ± 1.0 | 5.0 ± 1.0 | 4.0 ± 1.2 | 17.0 ± 2.2 |
hADMSCs (high) | 2.0 ± 1.1 | 2.5 ± 0.5 | 2.5 ± 1.5 | 1.5 ± 0.5 | 8.5 ± 2.51 |
hADMSCs (low) + TSP2 | 3.0 ± 0.2 | 1.5 ± 0.6 | 1.0 ± 0.4 | 2.0 ± 0.6 | 7.5 ± 0.51 |
TSP2 (100 ng) | 1.5 ± 1.5 | 3.5 ± 0.5 | 3.5 ± 1.5 | 3.0 ± 1.1 | 11.5 ± 4.51 |
- Citation: Shin K, Cha Y, Ban YH, Seo DW, Choi EK, Park D, Kang SK, Ra JC, Kim YB. Anti-osteoarthritis effect of a combination treatment with human adipose tissue-derived mesenchymal stem cells and thrombospondin 2 in rabbits. World J Stem Cells 2019; 11(12): 1115-1129
- URL: https://www.wjgnet.com/1948-0210/full/v11/i12/1115.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v11.i12.1115